3- ( 2-carboxypiperazin-4-yl ) propyl-1-phosphonic acid ( cpp ) , a novel antagonist at the n-methyl-d-aspartate ( nmda ) -preferring subtype of excitatory amino acid receptor , was evaluated in four rodent models of epilepsy , i.e . maximal electroshock seizures and pentylenetetrazol ( ptz ) -induced seizures in mice , epileptic gerbils and amygdala-kindled rats .
C0036572
seizures
C0014544
epileptic